Penserra Capital Management LLC Decreases Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Penserra Capital Management LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 32.4% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 3,232 shares of the medical equipment provider’s stock after selling 1,548 shares during the period. Penserra Capital Management LLC’s holdings in Intuitive Surgical were worth $1,587,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of the stock. Waverly Advisors LLC lifted its position in Intuitive Surgical by 27.1% in the first quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock valued at $1,018,000 after purchasing an additional 544 shares during the last quarter. Kennedy Capital Management LLC bought a new stake in Intuitive Surgical during the 1st quarter valued at $2,545,000. B. Riley Wealth Advisors Inc. boosted its position in Intuitive Surgical by 26.1% during the 1st quarter. B. Riley Wealth Advisors Inc. now owns 7,466 shares of the medical equipment provider’s stock valued at $2,980,000 after buying an additional 1,545 shares during the period. Creekmur Asset Management LLC grew its holdings in Intuitive Surgical by 200.0% in the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock worth $25,000 after acquiring an additional 42 shares during the last quarter. Finally, Tidal Investments LLC increased its position in shares of Intuitive Surgical by 11.5% in the first quarter. Tidal Investments LLC now owns 16,560 shares of the medical equipment provider’s stock valued at $6,609,000 after acquiring an additional 1,710 shares during the period. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Gary Loeb sold 300 shares of Intuitive Surgical stock in a transaction on Monday, September 9th. The stock was sold at an average price of $475.00, for a total value of $142,500.00. Following the completion of the sale, the general counsel now directly owns 1,595 shares of the company’s stock, valued at approximately $757,625. The trade was a 15.83 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 50,647 shares of company stock valued at $26,170,907. 0.80% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on ISRG. Stifel Nicolaus raised their target price on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a research note on Friday, October 18th. Truist Financial lifted their price objective on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Erste Group Bank upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Redburn Atlantic upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and upped their price objective for the stock from $380.00 to $510.00 in a report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $526.06.

Intuitive Surgical Stock Up 1.0 %

Shares of ISRG opened at $542.10 on Wednesday. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The stock has a market cap of $193.09 billion, a P/E ratio of 87.15, a P/E/G ratio of 5.39 and a beta of 1.39. The business’s 50 day moving average price is $506.81 and its 200-day moving average price is $466.29.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.